Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y12 receptor when interacting with antagonists

被引：34

作者：

Ding, Z. ^{[1
,2
]}

Bynagari, Y. S. ^{[1
]}

Mada, S. R. ^{[1
]}

Jakubowski, J. A. ^{[3
]}

Kunapuli, S. P. ^{[1
,2
,4
]}

机构：

[1] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA

[2] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA

[3] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA

[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 01期

关键词：

PLATELET ADP RECEPTOR; ACTIVE METABOLITE; IDENTIFICATION;

D O I：

10.1111/j.1538-7836.2008.03202.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：232 / 234

页数：3

共 12 条

[1] Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270
Ding, ZR
Kim, S
Dorsam, RT
Jin, JG
Kunapuli, SP
[J]. BLOOD, 2003, 101 (10) : 3908 - 3914
[2] Central role of the P2Y12 receptor in platelet activation
Dorsam, RT
Kunapuli, SP
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) : 340 - 345
[3] Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs
Foster, CJ
Prosser, DM
Agans, JM
Zhai, Y
Smith, MD
Lachowicz, JE
Zhang, FL
Gustafson, E
Monsma, FJ
Wiekowski, MT
Abbondanzo, SJ
Cook, DN
Bayne, ML
Lira, SA
Chintala, MS
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (12) : 1591 - 1598
[4] Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G
Jantzen, HM
Vincent, D
Li, G
England, L
Ramakrishnan, V
Yang, RB
Nurden, P
Nurden, A
Julius, D
Conley, PB
[J]. NATURE, 2001, 409 (6817) : 202 - 207
[5] Prasugrel: A novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile
Jakubowski, Joseph A.
Winters, Kenneth J.
Naganuma, Hideo
Wallentin, Lars
[J]. CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (04): : 357 - 374
[6] Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
Jin, JG
Kunapuli, SP
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8070 - 8074
[7] Identification and biological activity of the active metabolite of clopidogrel
Savi, P
Pereillo, JM
Uzabiaga, MF
Combalbert, J
Picard, C
Maffrand, JP
Pascal, M
Herbert, JM
[J]. THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) : 891 - 896
[8] P2Y12, a new platelet ADP receptor, target of clopidogrel
Savi, P
Labouret, C
Delesque, N
Guette, F
Lupker, J
Herbert, JM
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) : 379 - 383
[9] The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts
Savi, Pierre
Zachayus, Jean-Luc
Delesque-Touchard, Nathalie
Labouret, Catherine
Herve, Caroline
Uzabiaga, Marie-Francoise
Pereillo, Jean-Marie
Culouscou, Jean-Michel
Bono, Francoise
Ferrara, Pascual
Herbert, Jean-Marc
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (29) : 11069 - 11074
[10] Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type Gi-linked P2T antagonist, CS-747
Sugidachi, A
Asai, F
Yoneda, K
Iwamura, R
Ogawa, T
Otsuguro, K
Koike, H
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (01) : 47 - 54

← 1 2 →